Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia

Leukemia Research

Volumn 45, Issue , 2016, Pages 75-81

  Goasguen, Jean E ^a   Bennett, John M ^b   Bain, Barbara J ^c   Brunning, Richard D ^d   Vallespí, Maria Teresa ^e   Tomonaga, Masao ^f   Zini, Gina ^g   Renault, Alain ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITY OF ROCHESTER   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF MINNESOTA   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITY OF NAGASAKI   (Japan)

^g CATHOLIC UNIVERSITY   (Italy)

Author keywords

Dysmegakaryocytopoiesis; Dysmegakaryopoiesis; Dysmyelopoiesis; Dysplastic features; Megakaryocytes; Myelodysplastic syndrome

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL CRISIS; BONE MARROW TUMOR; CELL STRUCTURE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DYSMEGAKARYOPOIESIS; DYSPLASIA; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEGAKARYOBLAST; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MULTINUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; QUALITY CONTROL; TRANSIENT ABNORMAL MYELOPOIESIS; CELL SHAPE; CELL SIZE; HEMATOLOGIC DISEASE; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; PATHOLOGY;

CELL SHAPE; CELL SIZE; HEMATOLOGIC NEOPLASMS; HUMANS; MEGAKARYOCYTE PROGENITOR CELLS; MEGAKARYOCYTES; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; QUALITY CONTROL;

EID: 84963904860     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2016.04.009     Document Type: Article

References (16)

1. Minot G.R. Megakaryocytes in the peripheral circulation. J. Exp. Med. 1922, 36:1.
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D., Gralnick H. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982, 51:189-199.
3. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D., Gralnick H. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7): a report of the French-American-British Cooperative Group. Ann. Intern. Med. 1985, 103:460-462.
4. Brunning R.D., Orazi A., Germing U., le Beau M.M., Porwit A., Bauman I., et al. Myelodysplastic syndromes/neoplasms, overview. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 88-93. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
5. Arber D.A., Brunning R.D., Orazi A., Bain B.J., Porwit A., Vardiman J.W., et al. Acute myeloid leukaemia with myelodysplasia-related changes. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 124-126. IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
6. Arber D.A., Hasserjian R.P. Reclassifying myelodysplastic syndromes: what's where in the new WHO and why. Hematology 2015, 2015:294-298.
7. Kuriyama K., Tomonaga M., Matsuo T., Ginnai I., Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micromegakaryocytes in myelodysplastic syndrome. Br. J. Haematol. 1986, 63:665-669.
8. Bain B.J. The bone marrow aspirate of healthy subjects. Br. J. Haematol. 1996, 94:206-209.
9. Maldonado J.E. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. II ultrastructure of circulating megakaryocytes. Blood 1974, 43:811-820.
10. Duchayne E., Fenneteau O., Pages M.P., Sainty D., Arnoulet C., Dastugue N. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Francais d'Hematologie Cellulaire (GFHC). Leuk. Lymphoma 2003, 44:49-58.
11. Litz C.E., Davies S., Brunning R.D., Kurk B., Parkin J.L., Gajl Peczalska K.J. Acute leukemia and transient myeloproliferative disorder associated with Down syndrome: morphologic immunophenotypic and cytogenetic manifestations. Leukemia 1995, 9:1432-1439.
12. Franzén S., Strenger G., Zajicek J. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera. Acta Haematol. 1961, 26:182-193.
13. Matsuda A., Jinnai I., Miyazaki Y. Tomonaga: proposals for a grading system for diagnostic accuracy of myelodysplastic syndromes. Clin. Leuk. 2008, 2:102-106.
14. Germing U., Gattermann N., Aivido M., Hildebrandt B., Aul C. Two types of acquired sideroblastic anaemia (AISA): a time-tested distinction. Br. J. Haematol. 2000, 108:724-728.
15. Matsuda A., Germing U., Jinnai I., Iwanaga M., Misumi M., Kuendgen A. Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification. Leukemia 2007, 21:678-686.
16. Della Porta M.G., Travaglino E., Boveri E., Ponzoni M., Malcovati L., Papaemmanuil E. on behalf of Rete Ematologica Lombarda (REL) clinical network in 2014. Myelodysplasias: minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes. Leukemia 2015, 29:66-75.